Wall Street Is Wrong About This Quantum Computing Stock for 2026 -- Here's the Proof
Infleqtion (INFQ) became the first publicly listed neutral-atom quantum company in Feb. 2026 after a SPAC merger with gross proceeds of $550M+ and trades around $17.50 in early June. The company says it sells quantum sensing hardware under U.S., U.K., and Australian defense contracts and received a May 2026 U.S. Commerce LOI for $100M CHIPS Act funding tied to milestones. It also notes federal quantum grants and $3.9M for chemistry innovation. Risks include pre-profitability and milestone/contra
Government co-investment and defense-linked revenue claims are near-term catalysts for INFQ sentiment and risk premium.
Infleqtion secured a $100M U.S. CHIPS Act LOI with milestone conditions and equity at a 15% discount, plus defense sensing contracts and Nvidia NVQLink demo.
Bullish bias with potential volatility around milestone/contract conversion; initial reaction likely positive given LOI size and defense framing.
Background
The piece argues Wall Street underestimates Infleqtion by focusing on its neutral-atom quantum sensing/computing commercialization and government backing rather than only long-dated quantum computing breakthroughs.
Why it matters
The core tradable change is the $100M CHIPS Act LOI structure (milestones + equity discount) combined with defense-contract revenue claims and an Nvidia NVQLink integration demo, which can shift valuation expectations for early-stage quantum hardware.
Market relevance
INFQ is positioned as a near-term government-funded quantum hardware winner, but the LOI/milestone structure keeps execution risk elevated.
Market effects
Strengthens the “quantum sensing + defense procurement” thesis versus pure-play quantum computing, potentially improving read-through for other government-leaning quantum hardware names.
U.S. CHIPS Act framing may concentrate attention from U.S. defense/industrial tech investors on domestic quantum supply chains.
U.K. and Australia defense contract mentions support broader allied procurement interest, though the funding catalyst is U.S.-centric.
Alternative perspectives
Because the $100M is an LOI tied to milestones (not a signed contract), the market may be overpricing near-term certainty versus execution probability.
Pre-profitability and government-dependence raise downside if milestones slip; also, the Nvidia booth integration is promotional and may not translate into measurable commercial orders quickly.
Key entities
- companyInfleqtion
Neutral-atom quantum computing/sensing company; subject of the article’s funding and defense-contract claims.
- government_agencyU.S. Department of Commerce
Signed the $100M CHIPS Act letter of intent with Infleqtion tied to technical milestones.
- technology_companyNvidia
Showcased Infleqtion’s Sqale system at GTC 2026 with NVQLink integration mentioned in the article.
